If You... |
You May Be Eligible for Help From: |
|---|---|
Need help understanding your health insurance coverage and costs related to Rituxan? |
Rituxan Immunology Access Solutions works with your doctor, health insurance company, and specialty pharmacy to help you get your Rituxan |
Don't have health insurance coverage or your insurance doesn’t cover enough of the cost of your Rituxan? |
The Genentech Patient Foundation
|
Have health insurance and can't pay for your Rituxan? |
Affordability Options
‡The final amount owed by patients may be as little as $5, but may vary depending on the patient's health insurance plan. Eligible commercially insured patients who are prescribed Rituxan for an FDA-approved use can receive up to $15,000 in assistance annually for drug costs and/or up to $2,000 in infusion assistance annually for Rituxan infusion costs. See terms and conditions for each program. Program limits apply. |
Aren’t sure what you need? |
Genentech Patient Resource Center
|
*If you have health insurance, you should try to get other types of financial assistance, if available. You also need to meet income requirements. If you do not have insurance, or if your insurance does not cover your Genentech medicine, you must meet a different set of income requirements.
†The Rituxan Product and Administrative Co-pay Program is valid ONLY for patients with commercial insurance who have a valid prescription for a Food and Drug Administration (FDA)-approved indication of a Genentech medication. Patients using Medicare, Medicaid or any other federal or state government program to pay for their medications are not eligible. To receive co-pay assistance for both drug cost and administration fees, patients must apply for and be enrolled in each type of program benefit, (i.e., drug cost and administration fees).
Under the programs, the patient will pay a co-pay for drug costs and a co-pay for administration costs. After reaching the maximum per treatment or annual limit, the patient will be responsible for all remaining out-of-pocket expenses. The amount of the program’s benefits cannot exceed the patient’s out-of-pocket expenses for the cost of the drug or administration fees associated with the Rituxan.
All participants are responsible for reporting the receipt of all program benefits as required by any insurer or by law. The programs are only valid in the United States and U.S. Territories. These programs are void where prohibited by law. The product co-pay program shall follow state restrictions in relation to AB-rated generic equivalents (e.g., MA, CA) where applicable. The administration co-pay program is not valid for Massachusetts or Rhode Island residents. The patient, guardian, prescriber, hospital and any other person using or administering the programs agree not to seek reimbursement for all or any part of the benefit received by the patient through the offer of this program. Genentech reserves the right to rescind, revoke or amend the program without notice at any time. Additional Terms and Conditions apply. Please visit RACopay.com for the full list of Terms and Conditions.
§Independent co-pay assistance foundations have their own rules for eligibility. Genentech has no involvement or influence in independent foundation decision-making or eligibility criteria and does not know if a foundation will be able to help you. We can only refer you to a foundation that supports your disease state. This information is provided as a resource for you. Genentech does not endorse or show preference for any particular foundation. The foundations in this list may not be the only ones that might be able to help you.